<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Digital Diagnostics</journal-id><journal-title-group><journal-title xml:lang="en">Digital Diagnostics</journal-title><trans-title-group xml:lang="ru"><trans-title>Digital Diagnostics</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Digital Diagnostics</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2712-8490</issn><issn publication-format="electronic">2712-8962</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">561354</article-id><article-id pub-id-type="doi">10.17816/DD561354</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Case reports</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Клинические случаи и серии клинических случаев</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>临床病例及临床病例的系列</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Tissue sampling and histopathological limitations in esophageal cancer</article-title><trans-title-group xml:lang="ru"><trans-title>Ограничения использования гистологического исследования биоптатов как «золотого стандарта» диагностики на примере аденокарциномы пищевода: описание случая</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>将活检标本的组织学检查作为诊断“金标准”的局限性：一个例子</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7705-9754</contrib-id><contrib-id contrib-id-type="scopus">58104960900</contrib-id><contrib-id contrib-id-type="spin">6983-5991</contrib-id><name-alternatives><name xml:lang="en"><surname>Akhmedzyanova</surname><given-names>Dina A.</given-names></name><name xml:lang="ru"><surname>Ахмедзянова</surname><given-names>Дина Альфредовна</given-names></name><name xml:lang="zh"><surname>Akhmedzyanova</surname><given-names>Dina A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>AkhmedzyanovaDA@zdrav.mos.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3860-9853</contrib-id><name-alternatives><name xml:lang="en"><surname>Yutsevich</surname><given-names>Olga K.</given-names></name><name xml:lang="ru"><surname>Юцевич</surname><given-names>Ольга Константиновна</given-names></name><name xml:lang="zh"><surname>Yutsevich</surname><given-names>Olga K.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>o.yutsevitch@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9661-0254</contrib-id><contrib-id contrib-id-type="spin">8592-0558</contrib-id><name-alternatives><name xml:lang="en"><surname>Reshetnikov</surname><given-names>Roman V.</given-names></name><name xml:lang="ru"><surname>Решетников</surname><given-names>Роман Владимирович</given-names></name><name xml:lang="zh"><surname>Reshetnikov</surname><given-names>Roman V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Phys.-Math.)</p></bio><bio xml:lang="ru"><p>канд. ф.-м. наук</p></bio><bio xml:lang="zh"><p>Cand. Sci. (Phys.-Math.)</p></bio><email>r.reshetnikov@npcmr.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6759-6820</contrib-id><contrib-id contrib-id-type="spin">3658-1120</contrib-id><name-alternatives><name xml:lang="en"><surname>Tashchyаn</surname><given-names>Olga V.</given-names></name><name xml:lang="ru"><surname>Тащян</surname><given-names>Ольга Валерьевна</given-names></name><name xml:lang="zh"><surname>Tashchyаn</surname><given-names>Olga V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Med.)</p></bio><email>olgatash1@rambler.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8101-2155</contrib-id><contrib-id contrib-id-type="spin">7812-5502</contrib-id><name-alternatives><name xml:lang="en"><surname>Pirogov</surname><given-names>Sergey S.</given-names></name><name xml:lang="ru"><surname>Пирогов</surname><given-names>Сергей Сергеевич</given-names></name><name xml:lang="zh"><surname>Pirogov</surname><given-names>Sergey S.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д-р мед. наук</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Med.)</p></bio><email>pirogov@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4873-4455</contrib-id><contrib-id contrib-id-type="spin">4455-3055</contrib-id><name-alternatives><name xml:lang="en"><surname>Mazurova</surname><given-names>Maria P.</given-names></name><name xml:lang="ru"><surname>Мазурова</surname><given-names>Мария Павловна</given-names></name><name xml:lang="zh"><surname>Mazurova</surname><given-names>Maria P.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Med.)</p></bio><email>mnioi_morphology@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0421-4172</contrib-id><name-alternatives><name xml:lang="en"><surname>Volchenko</surname><given-names>Nadezhda N.</given-names></name><name xml:lang="ru"><surname>Волченко</surname><given-names>Надежда Николаевна</given-names></name><name xml:lang="zh"><surname>Volchenko</surname><given-names>Nadezhda N.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Med.), Professor</p></bio><email>mnioi_morphology@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7376-6056</contrib-id><contrib-id contrib-id-type="spin">1671-1600</contrib-id><name-alternatives><name xml:lang="en"><surname>Kamalov</surname><given-names>Aziz K.</given-names></name><name xml:lang="ru"><surname>Камалов</surname><given-names>Азиз Кураглиевич</given-names></name><name xml:lang="zh"><surname>Kamalov</surname><given-names>Aziz K.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kak6768@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8521-4045</contrib-id><contrib-id contrib-id-type="spin">3164-5518</contrib-id><name-alternatives><name xml:lang="en"><surname>Shumskaya</surname><given-names>Yuliya F.</given-names></name><name xml:lang="ru"><surname>Шумская</surname><given-names>Юлия Федоровна</given-names></name><name xml:lang="zh"><surname>Shumskaya</surname><given-names>Yuliya F.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ShumskayaYF@zdrav.mos.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9337-7453</contrib-id><contrib-id contrib-id-type="spin">2015-1822</contrib-id><name-alternatives><name xml:lang="en"><surname>Mnatsakanyan</surname><given-names>Marina G.</given-names></name><name xml:lang="ru"><surname>Мнацаканян</surname><given-names>Марина Генриковна</given-names></name><name xml:lang="zh"><surname>Mnatsakanyan</surname><given-names>Marina G.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Med.), Professor</p></bio><email>mnatsakanyan08@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies</institution></aff><aff><institution xml:lang="ru">Научно-практический клинический центр диагностики и телемедицинских технологий</institution></aff><aff><institution xml:lang="zh">Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Research Radiological Center</institution></aff><aff><institution xml:lang="ru">Московский научно-исследовательский онкологический институт имени П.А. Герцена — филиал Национального медицинского исследовательского центра Радиологии</institution></aff><aff><institution xml:lang="zh">P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Research Radiological Center</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">The First Sechenov Moscow State Medical University</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет имени И.М. Сеченова</institution></aff><aff><institution xml:lang="zh">The First Sechenov Moscow State Medical University</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-11-21" publication-format="electronic"><day>21</day><month>11</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2023</year></pub-date><volume>4</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>633</fpage><lpage>642</lpage><history><date date-type="received" iso-8601-date="2023-07-18"><day>18</day><month>07</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-11-16"><day>16</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Эко-вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2023, Eco-Vector</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-вектор</copyright-holder><copyright-holder xml:lang="zh">Eco-Vector</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://jdigitaldiagnostics.com/DD/article/view/561354">https://jdigitaldiagnostics.com/DD/article/view/561354</self-uri><abstract xml:lang="en"><p>Esophageal adenocarcinoma is a common gastrointestinal cancer. Esophagogastroduodenoscopy with biopsy and immunohistochemistry are used to detect the neoplasm at an early stage. Definitive diagnosis requires not only highly specialized equipment but also the skills of the endoscopist and pathologist. We report the case of a 35-year-old man with progressive dysphagia caused by gastroesophageal cancer. Numerous esophagogastroduodenoscopy studies, computed tomography, and barium X-ray swallow revealed an extensive esophageal lesion; however, pathomorphologic examinations did not confirm malignancy within a year. Histological studies showed pyloric gland adenoma and adenoma from parietal or oncocytic cells with high-grade dysplasia. Esophagogastroduodenoscopy with targeted biopsy at a specialized center confirmed the tumor malignancy. This clinical case demonstrates the importance of summing clinical symptoms and using additional instrumental methods to make a definitive diagnosis if biopsy results are ambiguous.</p></abstract><trans-abstract xml:lang="ru"><p>Аденокарцинома пищевода — одно из самых распространённых злокачественных новообразований желудочно-кишечного тракта. Для выявления заболевания на ранних стадиях используют эндоскопические, морфологические, иммуногистохимические методы обследования, однако они требуют не только применения высокоспециализированного оборудования, но и зависят от профессионализма врача-эндоскописта и врача-патоморфолога.</p> <p>В статье описано клиническое наблюдение пациента с прогрессирующей дисфагией, вызванной опухолью пищевода, распространяющейся на субкардиальный отдел желудка, которую не удавалось патоморфологически верифицировать в течение одного года. Данные эзофагогастродуоденоскопии, выполненной в медицинской организации по месту жительства, компьютерной томографии и рентгеноскопии пищевода с двойным контрастированием не оставляли сомнений в злокачественности новообразования, однако результаты многочисленных гистологических исследований свидетельствовали в пользу аденомы пилорических желёз, аденомы из париетальных, либо онкоцитарных клеток с фокусами дисплазии эпителия высокой степени. Эндоскопическое исследование с таргетированной биопсией в условиях специализированного учреждения позволило доказать злокачественность опухолевого процесса.</p> <p>Результаты исследования демонстрируют важность клинической картины и инструментальных методов для постановки заключительного диагноза при противоречивых данных патоморфологических исследований и в очередной раз поднимают проблему ограничений гистологического исследования биоптатов как «золотого стандарта» диагностики злокачественных новообразований.</p></trans-abstract><trans-abstract xml:lang="zh"><p>食管腺癌是胃肠道最常见的恶性肿瘤之一。为了在早期阶段发现这种疾病，医生采用内窥镜、形态学、免疫组化等检查方法。但是，这些方法不仅需要使用高度专业化的设备，还取决于内镜医师和病理形态学医师的专业水平。</p> <p>本文描述了对一名进行性吞咽困难患者的临床观察。吞咽困难是由食道肿瘤引起的。肿瘤已扩散到胃的贲门下段。肿瘤在一年内无法进行病理形态学验证。在居住地医疗机构进行的食管胃十二指肠镜检查、电子计算机断层扫描和食管双对比透视检查的数据证实了肿瘤的恶性程度。然而，大量组织学检查的结果都支持幽门腺腺瘤、顶体腺瘤或带有高度上皮发育不良病灶的肿瘤细胞腺瘤。在专业机构的条件下，通过内窥镜检查和靶向活检，才有可能证实肿瘤的恶性程度。</p> <p>研究结果表明，在病理形态学检查数据相互矛盾的情况下，临床表现和仪器方法对最终诊断的重要。这再次提出活检标本的组织学检查作为诊断恶性肿瘤“金标准”的局限性问题。</p></trans-abstract><kwd-group xml:lang="en"><kwd>esophageal adenocarcinoma</kwd><kwd>Barrett’s esophagus</kwd><kwd>gastroesophageal junction</kwd><kwd>esophagogastroduodenoscopy</kwd><kwd>computed tomography</kwd><kwd>biopsy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аденокарцинома пищевода</kwd><kwd>пищевод Барретта</kwd><kwd>кардиоэзофагеальный переход</kwd><kwd>эзофагогастродуоденоскопия</kwd><kwd>компьютерная томография</kwd><kwd>биопсия</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>食管腺癌</kwd><kwd>巴雷特食管</kwd><kwd>食管贲门交界处</kwd><kwd>食管胃十二指肠镜检查</kwd><kwd>电子计算机断层扫描</kwd><kwd>活检</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Департамент здравоохранения города Москвы</institution></institution-wrap><institution-wrap><institution xml:lang="en">Moscow Health Care Department</institution></institution-wrap><institution-wrap><institution xml:lang="zh">Moscow Health Care Department</institution></institution-wrap></funding-source><award-id>123031400009-1</award-id></award-group><funding-statement xml:lang="en">This paper was prepared by a group of authors as a part of the research and development effort titled “Opportunistic screening of high-profile and other common diseases”, No. 123031400009-1”, (USIS No. 123031400009-1 ) in accordance with the Order No. 1196 dated December 21, 2022 "On approval of state assignments funded by means of allocations from the budget of the city of Moscow to the state budgetary (autonomous) institutions subordinate to the Moscow Health Care Department, for 2023 and the planned period of 2024 and 2025" issued by the Moscow Health Care Department</funding-statement><funding-statement xml:lang="ru">Данная статья подготовлена авторским коллективом в рамках НИР «Оппортунистический скрининг социально значимых и иных распространённых заболеваний», (№ ЕГИСУ: № 123031400009-1 ) в соответствии с Приказом от 21.12.2022 г. № 1196 "Об утверждении государственных заданий, финансовое обеспечение которых осуществляется за счет средств бюджета города Москвы государственным бюджетным (автономным) учреждениям подведомственным Департаменту здравоохранения города Москвы, на 2023 год и плановый период 2024 и 2025 годов" Департамента здравоохранения города Москвы</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492</mixed-citation><mixed-citation xml:lang="ru">Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA Cancer J Clin. 2018. Vol. 68, N 6. P. 394–424. doi: 10.3322/caac.21492</mixed-citation><mixed-citation xml:lang="zh">Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">McColl KEL. What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East? J Gastroenterol. 2019;54(8):669–673. doi: 10.1007/s00535-019-01593-7</mixed-citation><mixed-citation xml:lang="ru">McColl K.E.L. What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East? // J Gastroenterol. 2019. Vol. 54, N 8. P. 669–673. doi: 10.1007/s00535-019-01593-7</mixed-citation><mixed-citation xml:lang="zh">McColl KEL. What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East? J Gastroenterol. 2019;54(8):669–673. doi: 10.1007/s00535-019-01593-7</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Joseph A, Raja S, Kamath S, et al. Esophageal adenocarcinoma: A dire need for early detection and treatment. Cleve Clin J Med. 2022;89(5):269–279. doi: 10.3949/ccjm.89a.21053</mixed-citation><mixed-citation xml:lang="ru">Joseph A., Raja S., Kamath S., et al. Esophageal adenocarcinoma: A dire need for early detection and treatment // Cleve Clin J Med. 2022. Vol. 89, N 5. P. 269–279. doi: 10.3949/ccjm.89a.21053</mixed-citation><mixed-citation xml:lang="zh">Joseph A, Raja S, Kamath S, et al. Esophageal adenocarcinoma: A dire need for early detection and treatment. Cleve Clin J Med. 2022;89(5):269–279. doi: 10.3949/ccjm.89a.21053</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–1021. doi: 10.1007/s12328-020-01237-x</mixed-citation><mixed-citation xml:lang="ru">Uhlenhopp D.J., Then E.O., Sunkara T., Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors // Clin J Gastroenterol. 2020. Vol. 13, N 6. P. 1010–1021. doi: 10.1007/s12328-020-01237-x</mixed-citation><mixed-citation xml:lang="zh">Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–1021. doi: 10.1007/s12328-020-01237-x</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang HY, Spechler SJ, Souza RF. Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett. 2009;275(2):170–177. doi: 10.1016/j.canlet.2008.07.006</mixed-citation><mixed-citation xml:lang="ru">Zhang H.Y., Spechler S.J., Souza R.F. Esophageal adenocarcinoma arising in Barrett esophagus // Cancer Lett. 2009. Vol. 275, N 2. P. 170–177. doi: 10.1016/j.canlet.2008.07.006</mixed-citation><mixed-citation xml:lang="zh">Zhang HY, Spechler SJ, Souza RF. Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett. 2009;275(2):170–177. doi: 10.1016/j.canlet.2008.07.006</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Deng HY, Alai G, Luo J, et al. Cancerous esophageal stenosis before treatment was significantly correlated to poor prognosis of patients with esophageal cancer: a meta-analysis. J Thorac Dis. 2018;10(7):4212–4219. doi: 10.21037/jtd.2018.06.89</mixed-citation><mixed-citation xml:lang="ru">Deng H.Y., Alai G., Luo J., et al. Cancerous esophageal stenosis before treatment was significantly correlated to poor prognosis of patients with esophageal cancer: a meta-analysis // J Thorac Dis. 2018. Vol. 10, N 7. P. 4212–4219. doi: 10.21037/jtd.2018.06.89</mixed-citation><mixed-citation xml:lang="zh">Deng HY, Alai G, Luo J, et al. Cancerous esophageal stenosis before treatment was significantly correlated to poor prognosis of patients with esophageal cancer: a meta-analysis. J Thorac Dis. 2018;10(7):4212–4219. doi: 10.21037/jtd.2018.06.89</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Sillah K, Pritchard SA, Watkins GR, et al. The degree of circumferential tumour involvement as a prognostic factor in oesophageal cancer. Eur J Cardiothorac Surg. 2009;36(2):368–373. doi: 10.1016/j.ejcts.2008.12.052</mixed-citation><mixed-citation xml:lang="ru">Sillah K., Pritchard S.A., Watkins G.R., et al. The degree of circumferential tumour involvement as a prognostic factor in oesophageal cancer // Eur J Cardiothorac Surg. 2009. Vol. 36, N 2. P. 368–373. doi: 10.1016/j.ejcts.2008.12.052</mixed-citation><mixed-citation xml:lang="zh">Sillah K, Pritchard SA, Watkins GR, et al. The degree of circumferential tumour involvement as a prognostic factor in oesophageal cancer. Eur J Cardiothorac Surg. 2009;36(2):368–373. doi: 10.1016/j.ejcts.2008.12.052</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Deng HY, Li G, Luo J. Does oesophageal stenosis have any impact on survival of oesophageal cancer patients? Interact Cardiovasc Thorac Surg. 2018;27(3):384–386. doi: 10.1093/icvts/ivy095</mixed-citation><mixed-citation xml:lang="ru">Deng H.Y., Li G., Luo J. Does oesophageal stenosis have any impact on survival of oesophageal cancer patients? // Interact Cardiovasc Thorac Surg. 2018. Vol. 27, N 3. P. 384–386. doi: 10.1093/icvts/ivy095</mixed-citation><mixed-citation xml:lang="zh">Deng HY, Li G, Luo J. Does oesophageal stenosis have any impact on survival of oesophageal cancer patients? Interact Cardiovasc Thorac Surg. 2018;27(3):384–386. doi: 10.1093/icvts/ivy095</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Knight WRC, McEwen R, Byrne BE, et al. Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus. Eur J Surg Oncol. 2020;46(12):2257–2261. doi: 10.1016/j.ejso.2020.07.003</mixed-citation><mixed-citation xml:lang="ru">Knight W.R.C., McEwen R., Byrne B.E., et al. Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus // Eur J Surg Oncol. 2020. Vol. 46, N 12. P. 2257–2261. doi: 10.1016/j.ejso.2020.07.003</mixed-citation><mixed-citation xml:lang="zh">Knight WRC, McEwen R, Byrne BE, et al. Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus. Eur J Surg Oncol. 2020;46(12):2257–2261. doi: 10.1016/j.ejso.2020.07.003</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Morozov SP, editor. I-74 Informativeness of radial diagnostics methods in various pathological conditions of the organism. Section 2: Diagnostics of pathological conditions and diseases of the gastrointestinal tract. Moscow; 2018. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">И–74 Информативность методов лучевой диагностики при различных патологических состояниях организма. Раздел 2. Диагностика патологических состояний и заболеваний желудочно-кишечного тракта / под ред. С.П. Морозова. Москва, 2018.</mixed-citation><mixed-citation xml:lang="zh">Morozov SP, editor. I-74 Informativeness of radial diagnostics methods in various pathological conditions of the organism. Section 2: Diagnostics of pathological conditions and diseases of the gastrointestinal tract. Moscow; 2018. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Ishihara R, Goda K, Oyama T. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett’s esophagus. J Gastroenterol. 2019;54(1):1–9. doi: 10.1007/s00535-018-1491-x</mixed-citation><mixed-citation xml:lang="ru">Ishihara R., Goda K., Oyama T. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett’s esophagus // J Gastroenterol. 2019. Vol. 54, N 1. P. 1–9. doi: 10.1007/s00535-018-1491-x</mixed-citation><mixed-citation xml:lang="zh">Ishihara R, Goda K, Oyama T. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett’s esophagus. J Gastroenterol. 2019;54(1):1–9. doi: 10.1007/s00535-018-1491-x</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Zagajnova EV, Zagajnov VE, Gladkova ND, et al. Optical coherence tomography in surgical treatment of esophageal cancer. Grekov’s Bulletin of Surgery. 2007;166(2):22–26.</mixed-citation><mixed-citation xml:lang="ru">Загайнова Е.В., Загайнов В.Е., Гладкова Н.Д., и др. Оптическая когерентная томография при хирургическом лечении рака пищевода // Вестник хирургии имени И.И. Грекова. 2007. Т. 166(2. С. 22–26.</mixed-citation><mixed-citation xml:lang="zh">Zagajnova EV, Zagajnov VE, Gladkova ND, et al. Optical coherence tomography in surgical treatment of esophageal cancer. Grekov’s Bulletin of Surgery. 2007;166(2):22–26.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Davydov MI, Ter-Ovanesov MD, Stilidi IS, et al. Barrett’s esophagus: from theoretical foundations to practical recommendations. Practical oncology. 2003;4(2):109–119. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Давыдов М.И., Тер-Ованесов М.Д., Стилиди И.С., и др. Пищевод Барретта: от теоретических основ к практическим рекомендациям // Практическая онкология. 2003. Т. 4, № 2. С. 109–119.</mixed-citation><mixed-citation xml:lang="zh">Davydov MI, Ter-Ovanesov MD, Stilidi IS, et al. Barrett’s esophagus: from theoretical foundations to practical recommendations. Practical oncology. 2003;4(2):109–119. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Barber MS, Aronson JK, von Schoen-Angerer T, et al. CARe guidelines for case reports: explanation and elaboration document. Translation into Russian. Digital Diagnostics. 2022;3(1):16–42. doi: 10.17816/DD105291</mixed-citation><mixed-citation xml:lang="ru">Barber M.S., Aronson J.K., von Schoen-Angerer T., et al. Рекомендации CARE для описания случаев: разъяснения и уточнения // Digital Diagnostics. Vol. 3, N 1. C. 16–42. doi: 10.17816/DD105291</mixed-citation><mixed-citation xml:lang="zh">Barber MS, Aronson JK, von Schoen-Angerer T, et al. CARe guidelines for case reports: explanation and elaboration document. Translation into Russian. Digital Diagnostics. 2022;3(1):16–42. doi: 10.17816/DD105291</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Wani S, Rubenstein JH, Vieth M, Bergman J. Diagnosis and Management of Low-Grade Dysplasia in Barrett’s Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Gastroenterology. 2016;151(5):822–835. doi: 10.1053/j.gastro.2016.09.040</mixed-citation><mixed-citation xml:lang="ru">Wani S., Rubenstein J.H., Vieth M., Bergman J. Diagnosis and Management of Low-Grade Dysplasia in Barrett’s Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association // Gastroenterology. 2016. Vol. 151, N 5. P. 822–835. doi: 10.1053/j.gastro.2016.09.040</mixed-citation><mixed-citation xml:lang="zh">Wani S, Rubenstein JH, Vieth M, Bergman J. Diagnosis and Management of Low-Grade Dysplasia in Barrett’s Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Gastroenterology. 2016;151(5):822–835. doi: 10.1053/j.gastro.2016.09.040</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2018;154(2):421–436. doi: 10.1053/j.gastro.2017.07.041</mixed-citation><mixed-citation xml:lang="ru">di Pietro M., Canto M.I., Fitzgerald R.C. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy // Gastroenterology. 2018. Vol. 154, N 2. P. 421–436. doi: 10.1053/j.gastro.2017.07.041</mixed-citation><mixed-citation xml:lang="zh">di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2018;154(2):421–436. doi: 10.1053/j.gastro.2017.07.041</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Winiker M, Mantziari S, Figueiredo SG, et al. Accuracy of preoperative staging for a priori resectable esophageal cancer. Dis Esophagus. 2018;31(1):1–6. doi: 10.1093/dote/dox113</mixed-citation><mixed-citation xml:lang="ru">Winiker M., Mantziari S., Figueiredo S.G., et al. Accuracy of preoperative staging for a priori resectable esophageal cancer // Dis Esophagus. 2018. Vol. 31, N 1. P. 1–6. doi: 10.1093/dote/dox113</mixed-citation><mixed-citation xml:lang="zh">Winiker M, Mantziari S, Figueiredo SG, et al. Accuracy of preoperative staging for a priori resectable esophageal cancer. Dis Esophagus. 2018;31(1):1–6. doi: 10.1093/dote/dox113</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Elsadek HM, Radwan MM. Diagnostic Accuracy of Mucosal Biopsy versus Endoscopic Mucosal Resection in Barrett’s Esophagus and Related Superficial Lesions. Int Sch Res Notices. 2015;2015. doi: 10.1155/2015/735807</mixed-citation><mixed-citation xml:lang="ru">Elsadek H.M., Radwan M.M. Diagnostic Accuracy of Mucosal Biopsy versus Endoscopic Mucosal Resection in Barrett’s Esophagus and Related Superficial Lesions // Int Sch Res Notices. 2015. Vol. 2015. doi: 10.1155/2015/735807</mixed-citation><mixed-citation xml:lang="zh">Elsadek HM, Radwan MM. Diagnostic Accuracy of Mucosal Biopsy versus Endoscopic Mucosal Resection in Barrett’s Esophagus and Related Superficial Lesions. Int Sch Res Notices. 2015;2015. doi: 10.1155/2015/735807</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Tryakin AA, Besova NS, Volkov NM, et al. Practice guidelines for drug treatment of esophageal and gastroesophageal junction cancers. Malignant tumours (Zlokačestvennye opuholi). 2021;11(3S2-1):299–313. (In Russ). doi: 10.18027/2224-5057-2021-11-3s2-20</mixed-citation><mixed-citation xml:lang="ru">Трякин А.А., Бесова Н.С., Волков Н.М., и др. Практические рекомендации по лекарственному лечению рака пищевода и пищеводно-желудочного перехода // Злокачественные опухоли. 2021. Т. 11, № 3S2-1. С. 299–313. doi: 10.18027/2224-5057-2021-11-3s2-20</mixed-citation><mixed-citation xml:lang="zh">Tryakin AA, Besova NS, Volkov NM, et al. Practice guidelines for drug treatment of esophageal and gastroesophageal junction cancers. Malignant tumours (Zlokačestvennye opuholi). 2021;11(3S2-1):299–313. (In Russ). doi: 10.18027/2224-5057-2021-11-3s2-20</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(4):393–422. doi: 10.6004/jnccn.2023.0019</mixed-citation><mixed-citation xml:lang="ru">Ajani J.A., D’Amico T.A., Bentrem D.J., et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology // J Natl Compr Canc Netw. 2023. Vol. 21, N 4. P. 393–422. doi: 10.6004/jnccn.2023.0019</mixed-citation><mixed-citation xml:lang="zh">Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(4):393–422. doi: 10.6004/jnccn.2023.0019</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Ormsby AH, Petras RE, Henricks WH, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut. 2002;51(5):671–676. doi: 10.1136/gut.51.5.671</mixed-citation><mixed-citation xml:lang="ru">Ormsby A.H., Petras R.E., Henricks W.H., et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma // Gut. 2002. Vol. 51, N 5. P. 671–676. doi: 10.1136/gut.51.5.671</mixed-citation><mixed-citation xml:lang="zh">Ormsby AH, Petras RE, Henricks WH, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut. 2002;51(5):671–676. doi: 10.1136/gut.51.5.671</mixed-citation></citation-alternatives></ref></ref-list></back></article>
